Six out of nine automatic enrolment (AE) providers have no policy to prevent investments in companies that profit from chemical and biological weapons, according to analysis by ShareAction.
Its report - The Engagement Deficit published on 9 June - found this was the case for the Aviva, The People's Pension, Royal London, Scottish Widows, Aegon, and Standard Life default funds. Furt...
To continue reading this article...
Join Professional Pensions
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, analysis and opinion from the industry
- Receive our in-depth monthly magazine in either print or digital format
- Access our Sustainable Investment Hub covering news and opinion from thought leaders in the ESG space
- Receive important and breaking news stories selected by the Editors in our daily newsletter
- Hear from industry experts and other forward-thinking leaders
- Receive a monthly members-only newsletter with exclusive opinion pieces from leading industry experts and a feature from the magazine in advance of its release date
